Lannett Co Inc Press Releases

LCI 
$42.29
*  
1.79
4.42%
Get LCI Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading LCI now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Lannett Receives FDA Approval for Dorzolamide HCL with Timolol
12/18/2014 1:20:00 PM - Business Wire
▼-2.76 % Price Change since this news event. The Volume Ratio is 2.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett Names Michael Bogda as President
12/5/2014 7:54:00 AM - Business Wire
▼-10.95 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett to Present at the Oppenheimer 25th Annual Healthcare Conference on December 10
12/2/2014 7:54:00 AM - Business Wire
▼-8.78 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
11/3/2014 4:05:00 PM - Business Wire
▼-26.48 % Price Change since this news event. The Volume Ratio is 1.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett Announces Positive FDA Inspection Results
11/3/2014 7:54:00 AM - Business Wire
▼-25.44 % Price Change since this news event. The Volume Ratio is 1.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg
10/29/2014 2:28:00 PM - Business Wire
▼-17.64 % Price Change since this news event. The Volume Ratio is 1.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett to Present at the 2014 Credit-Suisse Healthcare Conference on November 11
10/29/2014 7:54:00 AM - Business Wire
▼-20.46 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lannett Announces Preliminary Fiscal 2015 First Quarter Net Sales of Approximately $93 Million, EPS between $0.91 and $0.94
10/23/2014 7:54:00 AM - Business Wire


Lannett Announces Preliminary Fiscal 2015 First Quarter Net Sales of Approximately $93 Million, EPS between $0.91 and $0.94
10/23/2014 7:54:00 AM - Business Wire
▼-5.43 % Price Change since this news event. The Volume Ratio is 2.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Lannett Company, Inc. Of Upcoming Deadline
10/16/2014 6:41:00 PM - Business Wire
▲1.41 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Class Action Lawsuit Against Lannett Voluntarily Dismissed Without Prejudice
9/30/2014 3:38:00 PM - Business Wire